NCT02609776 2026-04-13CHRYSALISJanssen Research & Development, LLCPhase 1 Active not recruiting751 enrolled 2 FDA
NCT03399799 2026-04-13MonumenTAL-1Janssen Research & Development, LLCPhase 1 Active not recruiting279 enrolled 2 FDA
NCT04886804 2026-03-13Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Boehringer IngelheimPhase 1 Active not recruiting608 enrolled 5 FDA
NCT02122913 2026-02-05A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat CancerBayerPhase 1 Completed75 enrolled 5 FDA